229 results
Page 2 of 12
SC TO-I
EX-99
xd69gx1 o3r
20 Aug 19
Issuer tender offer statement
5:01pm
8-K
EX-10.2
svi1nfe
7 Aug 19
Entry into a Material Definitive Agreement
4:45pm
SC TO-I/A
EX-99
8pari 2hky2t4r0ygv
6 Jun 19
Issuer tender offer statement (amended)
5:01pm
SC TO-I
EX-99
d6ki7lluqko
28 May 19
Issuer tender offer statement
5:26pm
S-8
ydf7u5y
3 May 19
Registration of securities for employees
5:06pm
S-8
EX-4.2
0ycrhb xf
3 May 19
Registration of securities for employees
5:06pm
8-K
EX-10.1
h4xwj0nstcr5pj8ipax
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
8-K
EX-10.2
be92xky n663
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
8-K
EX-99.1
umdwj4cnu lkxykp
7 Mar 19
Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
12:00am
8-K
EX-10.1
6he2c7 tdx89hk002c
3 Oct 18
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
8:30am
8-K
EX-10.1
jnfd3y2ndrn0autn q63
24 Sep 18
Marina Biotech Appoints Eric Teague as Chief Financial Officer
4:30pm
8-K
EX-10.1
6h3dwuvlpfyhyo
20 Jun 18
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
11:40am
8-K
EX-10.2
iy6hjaf 0sq
18 May 18
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
i5oo0yduk
24 Nov 17
Entry into a Material Definitive Agreement
12:00am